無料レポート プレゼントキャンペーン 実施中 : メールサービスに新規登録いただいた方にご用意した無料レポートをご提供

株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

心血管系医薬品の世界市場

Cardiovascular Drugs Global Market Report 2019

発行 The Business Research Company 商品コード 531324
出版日 ページ情報 英文 300 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=110.39円で換算しております。
Back to Top
心血管系医薬品の世界市場 Cardiovascular Drugs Global Market Report 2019
出版日: 2019年01月01日 ページ情報: 英文 300 Pages
概要

当レポートでは、世界の心血管系医薬品の市場を調査し、市場の定義と概要、市場への各種影響因子の分析、疾患区分・地域・国別の動向と市場規模の推移と予測、マクロ経済因子・ヘルスケア市場全体・各種産業指標との比較、競合環境、企業プロファイルなどをまとめています。

第1章 市場の特徴

第2章 市場規模・成長率

  • 市場成長:これまでの経緯
    • 成長推進因子
    • 成長抑制因子
  • 市場成長:予測
    • 成長推進因子
    • 成長抑制因子

第3章 PESTLE分析

第4章 顧客情報

第5章 心血管系医薬品市場の分析:区分別

  • 世界市場の実績:区分別
    • 高血圧治療薬
    • 脂質降下薬
    • 抗血栓薬
    • その他
      • 血性心不全
      • 抗不整脈薬
      • 狭心症治療薬
  • 世界市場の推移と予測:区分別
  • 市場動向・戦略

第6章 心血管系医薬品市場の分析:地域・国別分析

  • 世界市場の実績:地域別
  • 世界市場の推移と予測:地域別
  • 市場実績:国別
  • 市場の推移と予測:国別
  • 世界の医薬品市場の実績:区分・地域別
  • 世界の医薬品市場の実績:区分・国別

第7章 マクロ経済因子と市場の比較

  • 市場規模のGDPに占める割合
  • 一人当たりの平均支出額

第8章 マクロ経済因子と市場の比較:国別

  • 市場規模のGDPに占める割合:国別
  • 一人当たりの平均支出額:国別

第9章 産業指標と市場の比較

  • 世界の薬剤師数:国別
  • 市場収益 vs 薬剤師数:国別
  • 世界の医薬品会社数:国別
  • 市場収益 vs 医薬品会社数:国別
  • 世界のR&D/製品開発への平均支出額:国別
  • 市場収益 vs R&D/製品開発への平均支出額:国別
  • 世界のジェネリック&ブランド売上の割合:国別
  • 市場収益 vs ジェネリック&ブランド売上の割合:国別
  • 世界の一般開業医の数:国別
  • 市場収益 vs 一般開業医数:国別

第10章 アジア太平洋市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 中国
  • インド
  • 日本
  • オーストラリア

第11章 西欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン

第12章 東欧市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ロシア

第13章 北米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • 米国

第14章 南米市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別
  • 国別分析
  • ブラジル

第15章 中東市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第16章 アフリカ市場

  • 市場概要
  • 市場の過去の推移
  • 市場予測
  • 市場実績:区分別

第17章 競合環境

  • 企業プロファイル
  • Johnson & Johnson
  • Novartis Ag
  • F. Hoffmann-La Roche Ltd
  • Pfizer Inc.
  • Sanofi

第18章 主要M&A

第19章 市場背景:心血管系医薬品市場

第20章 ヘルスケア産業のファイナンシャルマージン

第21章 付録

目次

Cardiovascular Drugs Market Global Report 2019 from The Business Research Company provides the strategists, marketers and senior management with the critical information they need to assess the global cardiovascular drugs market.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Description:

Where is the largest and fastest growing market for the cardiovascular drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Cardiovascular Drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography. It places the market within the context of the wider pharmaceutical drugs market, and compares it with other markets.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market and forecasting the future. Drivers and restraints looks at the external factors supporting and controlling the growth of the market.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers all the regions, key developed countries and major emerging markets. It draws comparisons with country populations and economies to understand the importance of the market by country and how this is changing.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section highlights the likely future developments in the market and suggests approaches companies can take to exploit this.
  • The cardiovascular drugs market section of the report gives context. It compares the cardiovascular drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, cardiovascular drugs indicators comparison.

Scope

Markets Covered: Anti-Hypertensive Drugs, Hypolipidemics, Anti Thrombotics, Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

Companies Mentioned: Merck & Co, Sanofi S.A, Pfizer Inc, Bristol-Myers Squibb Company, Novartis AG

Metrics Covered: Hypertension Prevalence Rate, Number of Enterprises, Number of Employees

Countries: Argentina, Australia, Austria, Belgium, Brazil, Canada, Chile, China, Colombia, Czech Republic, Denmark, Egypt, Finland, France, Germany, Hong Kong, India, Indonesia, Ireland, Israel, Italy, Japan, Malaysia, Mexico, Netherlands, New Zealand, Nigeria, Norway, Peru, Philippines, Poland, Portugal, Romania, Russia, Saudi Arabia, Singapore, South Africa, South Korea, Spain, Sweden, Switzerland, Thailand, Turkey, UAE, UK, USA, Venezuela, Vietnam

Regions: Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Time series: Five years historic and forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, cardiovascular drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Table of Contents

1. Executive Summary

2. Report Structure

3. Cardiovascular Drugs Market Characteristics

  • 3.1. Market Definition
  • 3.2. Key Segmentations

4. Cardiovascular Drugs Market Product Analysis

  • 4.1. Leading Products/ Services
  • 4.2. Key Features and Differentiators
  • 4.3. Development Products

5. Cardiovascular Drugs Market Supply Chain

  • 5.1. Supply Chain
  • 5.2. Distribution
  • 5.3. End Customers

6. Cardiovascular Drugs Market Customer Information

  • 6.1. Customer Preferences
  • 6.2. End Use Market Size and Growth

7. Cardiovascular Drugs Market Trends And Strategies

8. Cardiovascular Drugs Market Size And Growth

  • 8.1. Market Size
  • 8.2. Historic Market Growth, Value ($ Billion)
    • 8.2.1. Drivers Of The Market
    • 8.2.2. Restraints On The Market
  • 8.3. Forecast Market Growth, Value ($ Billion)
    • 8.3.1. Drivers Of The Market
    • 8.3.2. Restraints On The Market

9. Cardiovascular Drugs Market Regional Analysis

  • 9.1. Global Cardiovascular Drugs Market, 2018, By Region, Value ($ Billion)
  • 9.2. Global Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 9.3. Global Cardiovascular Drugs Market, Growth And Market Share Comparison, By Region

10. Cardiovascular Drugs Market Segmentation

  • 10.1. Global Cardiovascular Drugs Market, Segmentation By Type, 2014 - 2022, Value ($ Billion)
    • 10.1.1. Anti-Hypertensive Drugs
    • 10.1.2. Hypolipidemics
    • 10.1.3. Anti Thrombotics
    • 10.1.4. Other Drugs For Cardiovascular Diseases (Congestive Heart Failure, Anti-Arrhythmic And Anti-Anginal Drugs)

11. Cardiovascular Drugs Market Metrics

  • 11.1. Cardiovascular Drugs Market Size, Percentage Of GDP, 2014 - 2022, Global
  • 11.2. Per Capita Average Cardiovascular Drugs Market Expenditure, 2014 - 2022, Global

12. Asia-Pacific Cardiovascular Drugs Market

  • 12.1. Asia-Pacific Cardiovascular Drugs Market Overview
  • 12.2. Asia-Pacific, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 12.3. Asia-Pacific, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 12.4. Asia-Pacific, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 12.5. Asia-Pacific, Cardiovascular Drugs Market Metrics
    • 12.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Asia-Pacific Countries
    • 12.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Asia-Pacific Countries
  • 12.6. Asia-Pacific Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 12.7. Asia-Pacific Cardiovascular Drugs Market: Country Analysis
    • 12.7.1. China Cardiovascular Drugs Market
      • 12.7.1.1. China Cardiovascular Drugs Market Overview
      • 12.7.1.2. China Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.1.3. China Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.1.4. China Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.2. Australia Cardiovascular Drugs Market
      • 12.7.2.1. Australia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.2.2. Australia Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.2.3. Australia Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.3. Hong Kong Cardiovascular Drugs Market
      • 12.7.3.1. Hong Kong Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.4. India Cardiovascular Drugs Market
      • 12.7.4.1. India Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.4.2. India Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.4.3. India Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.5. Indonesia Cardiovascular Drugs Market
      • 12.7.5.1. Indonesia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.6. Japan Cardiovascular Drugs Market
      • 12.7.6.1. Japan Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 12.7.6.2. Japan Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 12.7.6.3. Japan Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 12.7.7. Malaysia Cardiovascular Drugs Market
      • 12.7.7.1. Malaysia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.8. New Zealand Cardiovascular Drugs Market
      • 12.7.8.1. New Zealand Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.9. Philippines Cardiovascular Drugs Market
      • 12.7.9.1. Philippines Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.10. Singapore Cardiovascular Drugs Market
      • 12.7.10.1. Singapore Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.11. South Korea Cardiovascular Drugs Market
      • 12.7.11.1. South Korea Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.12. Thailand Cardiovascular Drugs Market
      • 12.7.12.1. Thailand Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 12.7.13. Vietnam Cardiovascular Drugs Market
      • 12.7.13.1. Vietnam Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

13. Western Europe Cardiovascular Drugs Market

  • 13.1. Western Europe Cardiovascular Drugs Market Overview
  • 13.2. Western Europe, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 13.3. Western Europe, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 13.4. Western Europe, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 13.5. Western Europe, Cardiovascular Drugs Market Metrics
    • 13.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Western Europe Countries
    • 13.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Western Europe Countries
  • 13.6. Western Europe Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 13.7. Western Europe Cardiovascular Drugs Market: Country Analysis
    • 13.7.1. Austria Cardiovascular Drugs Market
      • 13.7.1.1. Austria Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.2. Belgium Cardiovascular Drugs Market
      • 13.7.2.1. Belgium Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.3. Denmark Cardiovascular Drugs Market
      • 13.7.3.1. Denmark Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.4. Finland Cardiovascular Drugs Market
      • 13.7.4.1. Finland Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.5. France Cardiovascular Drugs Market
      • 13.7.5.1. France Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.5.2. France Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.5.3. France Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.6. Germany Cardiovascular Drugs Market
      • 13.7.6.1. Germany Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.6.2. Germany Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.6.3. Germany Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.7. Ireland Cardiovascular Drugs Market
      • 13.7.7.1. Ireland Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.8. Italy Cardiovascular Drugs Market
      • 13.7.8.1. Italy Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.8.2. Italy Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.8.3. Italy Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.9. Netherlands Cardiovascular Drugs Market
      • 13.7.9.1. Netherlands Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.10. Norway Cardiovascular Drugs Market
      • 13.7.10.1. Norway Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.11. Portugal Cardiovascular Drugs Market
      • 13.7.11.1. Portugal Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.12. Spain Cardiovascular Drugs Market
      • 13.7.12.1. Spain Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.12.2. Spain Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.12.3. Spain Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 13.7.13. Sweden Cardiovascular Drugs Market
      • 13.7.13.1. Sweden Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 13.7.14. Switzerland Cardiovascular Drugs Market
      • 13.7.14.1. Switzerland Cardiovascular Drugs Market2013 - 2022, Value ($ Billion)
    • 13.7.15. UK Cardiovascular Drugs Market
      • 13.7.15.1. UK Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 13.7.15.2. UK Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 13.7.15.3. UK Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

14. Eastern Europe Cardiovascular Drugs Market

  • 14.1. Eastern Europe Cardiovascular Drugs Market Overview
  • 14.2. Eastern Europe, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 14.3. Eastern Europe, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 14.4. Eastern Europe, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 14.5. Eastern Europe, Cardiovascular Drugs Market Metrics
    • 14.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Eastern Europe Countries
    • 14.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Eastern Europe Countries
  • 14.6. Eastern Europe Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 14.7. Eastern Europe Cardiovascular Drugs Market: Country Analysis
    • 14.7.1. Czech Republic Cardiovascular Drugs Market,
      • 14.7.1.1. Czech Republic Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.2. Poland Cardiovascular Drugs Market
      • 14.7.2.1. Poland Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.3. Romania Cardiovascular Drugs Market
      • 14.7.3.1. Romania Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 14.7.4. Russia Cardiovascular Drugs Market
      • 14.7.4.1. Russia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 14.7.4.2. Russia Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 14.7.4.3. Russia Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

15. North America Cardiovascular Drugs Market

  • 15.1. North America Cardiovascular Drugs Market Overview
  • 15.2. North America, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 15.3. North America, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 15.4. North America, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 15.5. North America, Cardiovascular Drugs Market Metrics
    • 15.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, North America Countries
    • 15.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, North America Countries
  • 15.6. North America Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 15.7. North America Cardiovascular Drugs Market: Country Analysis
    • 15.7.1. Canada Cardiovascular Drugs Market
      • 15.7.1.1. Canada Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.2. Mexico Cardiovascular Drugs Market
      • 15.7.2.1. Mexico Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 15.7.3. USA Cardiovascular Drugs Market
      • 15.7.3.1. USA Cardiovascular Drugs Market Overview
      • 15.7.3.2. USA Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 15.7.3.3. USA Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 15.7.3.4. USA Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

16. South America Cardiovascular Drugs Market

  • 16.1. South America Cardiovascular Drugs Market Overview
  • 16.2. South America, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 16.3. South America, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 16.4. South America, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 16.5. South America, Cardiovascular Drugs Market Metrics
    • 16.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, South America Countries
    • 16.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, South America Countries
  • 16.6. South America Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 16.7. South America Cardiovascular Drugs Market: Country Analysis
    • 16.7.1. Argentina Cardiovascular Drugs Market
      • 16.7.1.1. Argentina Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.2. Brazil Cardiovascular Drugs Market
      • 16.7.2.1. Brazil Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
      • 16.7.2.2. Brazil Cardiovascular Drugs Market, 2014 - 2022, Volume (Million Units)
      • 16.7.2.3. Brazil Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
    • 16.7.3. Chile Cardiovascular Drugs Market
      • 16.7.3.1. Chile Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.4. Colombia Cardiovascular Drugs Market
      • 16.7.4.1. Colombia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.5. Peru Cardiovascular Drugs Market
      • 16.7.5.1. Peru Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 16.7.6. Venezuela Cardiovascular Drugs Market
      • 16.7.6.1. Venezuela Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

17. Middle East Cardiovascular Drugs Market

  • 17.1. Middle East Cardiovascular Drugs Market Overview
  • 17.2. Middle East, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 17.3. Middle East, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 17.4. Middle East, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 17.5. Middle East, Cardiovascular Drugs Market Metrics
    • 17.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Middle East Countries
    • 17.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Middle East Countries
  • 17.6. Middle East Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 17.7. Middle East Cardiovascular Drugs Market: Country Analysis
    • 17.7.1. Saudi Arabia Cardiovascular Drugs Market
      • 17.7.1.1. Saudi Arabia Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.2. Israel Cardiovascular Drugs Market
      • 17.7.2.1. Israel Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.3. Turkey Cardiovascular Drugs Market
      • 17.7.3.1. Turkey Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 17.7.4. UAE Cardiovascular Drugs Market
      • 17.7.4.1. UAE Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

18. Africa Cardiovascular Drugs Market

  • 18.1. Africa Cardiovascular Drugs Market Overview
  • 18.2. Africa, Cardiovascular Drugs Market, 2018, By Country, Value ($ Billion)
  • 18.3. Africa, Cardiovascular Drugs Market, 2014 - 2022, Historic And Forecast, By Country
  • 18.4. Africa, Cardiovascular Drugs Market, 2014 - 2022, Growth And Market Share Comparison, By Country
  • 18.5. Africa, Cardiovascular Drugs Market Metrics
    • 18.5.1. Per Capita Average Cardiovascular Drugs Expenditure, 2014 - 2022, Africa Countries
    • 18.5.2. Hypertension Prevalence Rate, Cardiovascular Drugs Market, Cardiovascular Drugs Market/Hypertension Prevalence Rate, 2018, Africa Countries
  • 18.6. Africa Cardiovascular Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)
  • 18.7. Africa Cardiovascular Drugs Market: Country Analysis
    • 18.7.1. Egypt Cardiovascular Drugs Market
      • 18.7.1.1. Egypt Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.2. Nigeria Cardiovascular Drugs Market
      • 18.7.2.1. Nigeria Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)
    • 18.7.3. South Africa Cardiovascular Drugs Market
      • 18.7.3.1. South Africa Cardiovascular Drugs Market, 2014 - 2022, Value ($ Billion)

19. Cardiovascular Drugs Market Competitive Landscape

  • 19.1. Competitive Market Overview
  • 19.2. Market Shares
  • 19.3. Company Profiles
    • 19.3.1. Merck & Co
      • 19.3.1.1. Company Overview
      • 19.3.1.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.1.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.1.4. Financial Performance
    • 19.3.2. Sanofi S.A
      • 19.3.2.1. Company Overview
      • 19.3.2.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.2.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.2.4. Financial Performance
    • 19.3.3. Pfizer Inc
      • 19.3.3.1. Company Overview
      • 19.3.3.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.3.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.3.4. Financial Performance
    • 19.3.4. Bristol-Myers Squibb Company
      • 19.3.4.1. Company Overview
      • 19.3.4.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.4.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.4.4. Financial Performance
    • 19.3.5. Novartis AG
      • 19.3.5.1. Company Overview
      • 19.3.5.2. Company Cardiovascular Drugs Market Structure And Strategy
      • 19.3.5.3. Company Cardiovascular Drugs Market Products And Services
      • 19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Cardiovascular Drugs Market

21. Market Background: Pharmaceutical Drugs Market

  • 21.1. Pharmaceutical Drugs Market Characteristics
  • 21.2. Pharmaceutical Drugs Market Historic and Forecast, 2014 - 2022 Growth, by segment, Value ($ Billion), Global
  • 21.3. Global Pharmaceutical Drugs Market, 2018, By Region, Value ($ Billion)
  • 21.4. Global Pharmaceutical Drugs Market, 2014 - 2022, Historic And Forecast, By Region
  • 21.5. Global Pharmaceutical Drugs Market, 2014 - 2022, Segmentation By Type, Value ($ Billion)

22. Recommendations

  • 22.1. Global Cardiovascular Drugs Market In 2022- Growth Countries
  • 22.2. Global Cardiovascular Drugs Market In 2022- Growth Segments
  • 22.3. Global Cardiovascular Drugs Market In 2022- Growth Strategies

23. Appendix

  • 23.1. NAICS Definitions Of Industry Covered In This Report
  • 23.2. Abbreviations
  • 23.3. Currencies
  • 23.4. Research Inquiries
  • 23.5. The Business Research Company

24. Copyright And Disclaimer

Back to Top